Viewing StudyNCT04671615



Ignite Creation Date: 2024-05-06 @ 3:34 PM
Last Modification Date: 2024-10-26 @ 1:52 PM
Study NCT ID: NCT04671615
Status: COMPLETED
Last Update Posted: 2023-10-30
First Post: 2020-11-24

Brief Title: A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Keywords:
Name View
positivehuman epidermal growth factor 2 - negative HRHER2- View
hormone receptor View